The sensitivity and specificity of serum CEA for detection of malignant BC disease was 76.7% (95% CI = 57.7% to 90.1%) and 90.0% (95% CI =73.5% to 97.9%), respectively; where 2μg/L was considered as the cut-off level. The gene discussed is CEACAM5; the disease is breast cancer.